Semaglutide

Rybelsus has now been expanded to treat those at high risk of heart attack and stroke

Diabetes

First oral GLP-1 cuts cardiovascular risk by 14% – and it's now FDA-approved

The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of cardiovascular events like heart attack and stroke.

Although it's also a weekly injection, RES-010 works very differently than Ozempic and other drugs like it

Obesity

Ozempic killer? New drug reprograms metabolism for lasting weight loss

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the injections stop. A new drug targets weight loss differently, leading to a more permanent fat-shedding solution.

A small clinical trial has found Ozempic improves blood glucose in certain type 1 diabetics

Diabetes

Ozempic improves sugar control in certain type 1 diabetics, trial shows

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use an automated insulin delivery system. It’s hoped this will lead to the approval of Ozempic for this patient population.